Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision.
Employees: 1-10
Portfolio 8
| Date | Name | Website | Total Raised | Location |
| 21.08.2022 | Radius Hea... | radiuspharm.com | - | United Sta... |
| 08.12.2016 | Crossover ... | crossoverhealth.com | $275M | United Sta... |
| - | Naveris, I... | naveris.com | $51M | United Sta... |
| - | Early Alle... | spoonfulone.com | - | - |
| - | Innocoll | innocoll.com | - | United Sta... |
| - | Therapeuti... | corium.com | - | United Sta... |
| - | Tremeau Ph... | tremeau.com | - | United Sta... |
| - | Alladapt I... | alladapt.com | $119M | United Sta... |
Mentions in press and media 11
| Date | Title | Description |
| 21.09.2022 | Naveris Raises $51M for Early Detection of Viral-Driven Cancers | What You Should Know: Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. The company’s mission is to improve outcomes for the millions of people at risk of developing vira... |
| 27.11.2018 | Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million | Nov 27 2018 CAMBRIDGE, Mass.—(BUSINESS WIRE)—Gurnet Point Capital (“Gurnet Point”), a private investment firm focused on the healthcare and life sciences sectors, announced today that it has completed the previously announced tender offer ... |
| 27.06.2018 | Term Sheet — Wednesday, June 27 | DATING DRAMA Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop As the competition heats up, so does the pressure. My colleague Leigh Gallagher delves deep inside Match Group to und... |
| 11.06.2018 | In the heart of one of the biggest Life Sciences hubs - tales from a Swiss entrepreneur in Boston | In the heart of one of the biggest Life Sciences hubs - tales from a Swiss entrepreneur in Boston 11.06.2018 09:00, Charlotte Pichon linkedIn facebook twitter instagram youtube --> Venture Leaders Life Sciences team member Mathieu Horras... |
| 20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk | venture leaders Life Science 2017: Walk the investors’ talk 20.06.2017 10:00, Lara Rossi linkedIn facebook twitter instagram youtube --> From June 12 to 16, ten Swiss startups in Life Science rocked the Boston business and innovation hub... |
| 20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk | Monday: Rolling the pitch PAREXEL, 7:30AM. A short night after landing at Logan airport, the participants went to PAREXEL in a school bus. The day started with a presentation by CEO Josef H. von Rickenbach. PAREXEL actually started as a sta... |
| 08.12.2016 | Crossover Health Nabs $92M to Fuel Primary Care Technology Platform | Crossover Health, an Aliso Viejo, CA-based next generation provider of employee healthcare that develops on-site and near-site health centers, has raised $92 million in funding from Gurnet Point Capital, an investment firm focused on the he... |
| 26.11.2015 | USD 600 million for new drugs | |
| 21.11.2015 | Gurnet Point Capital Launches Boston Pharmaceuticals with $600M Commitment | Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and led by Christopher A. Viehbacher, created Boston Pharmaceuticals, a Cambridge, MA-based drug development... |
| 19.11.2015 | Ex-Sanofi CEO helps launch Boston Pharmaceuticals with $600M | Christopher Viehbacher, the former CEO of Sanofi and current Gurnet Point Capital managing partner, will serve as the company’s chairman. Robert Armstrong, former head of global R&D at Eli Lilly, will be Boston Pharmaceuticals’ chief ex... |
Show more